We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Learn more
Cookie Preferences
Manage your cookie preferences. You can enable or disable different types of cookies below.
Join the list! Get updates on new episodes!
Stay Connected with the podcast! Join our mailing list and get the latest updates, helpful resources, and patient education directly to your inbox.
Where informed patients make confident treatment decisions.
What if the surgeon sitting across from you told you that your thyroid cancer is not urgent — and that you have time to think, research, and explore all your options before committing to anything? That's exactly what Dr. Melanie Goldfarb tells her patients. And she's an endocrine surgeon. Dr. Goldfarb is a fellowship-trained endocrine surgeon, Professor of Surgery, and Director of the Center for Endocrine Tumors and Disorders at St. John's Cancer Institute in Santa Monica, California. As one of the first physicians on the West Coast to offer in-office RFA, she performs surgery AND ablation — so her recommendation reflects what's right for each patient, not the limits of what she can offer. In this episode she covers the full landscape of thyroid nodule and cancer treatment — from realistic RFA expectations to a combination approach that saves half a thyroid. In this episode: What realistic RFA volume reduction looks like — 50% is success but she aims for 70-80% Why goi…